Republicans To Cut Stem Cell Funding?

Most of the GOP presidential candidates would limit federal funding for human embryonic stem cell research.

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Presidential candidate Mitt RomneyFLICKR, GAGE SKIDMORE

Almost all of the Republican candidates for the 2012 presidential term would restrict federal funding for human embryonic stem cells (hESCs), which many scientists worry could hinder scientific advances in the field.

In 2001, Bush barred the National Institutes of Health from funding hESC research on all but 22 existing cell lines. In 2009, Obama overturned Bush’s law by executive order, allowing new hESC lines to apply for federal funding eligibility. Currently, there are 128 approved hESC lines for federal funding, and over the last two years, the NIH has provided more than $300 million to support research using those lines.

Of seven Republican candidates, all said they would not support expanding funding for new cell lines, and only John Huntsman and Newt Gingrich responded ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies